Literature DB >> 12173124

Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome.

David M Koelle1, Serge Barcy, Meei-Li Huang, Rhoda L Ashley, Lawrence Corey, Judy Zeh, Suzanne Ashton, Dedra Buchwald.   

Abstract

To estimate the prevalence of viruses associated with chronic fatigue syndrome (CFS) and to control for genetic and environmental factors, we conducted a co-twin control study of 22 monozygotic twin pairs, of which one twin met criteria for CFS and the other twin was healthy. Levels of antibodies to human herpesvirus (HHV)-8, cytomegalovirus, herpes simplex virus 1 and 2, and hepatitis C virus were measured. Polymerase chain reaction (PCR) assays for viral DNA were performed on peripheral blood mononuclear cell specimens to detect infection with HHV-6, HHV-7, HHV-8, cytomegalovirus, Epstein-Barr virus, herpes simplex virus, varicella zoster virus, JC virus, BK virus, and parvovirus B19. To detect lytic infection, plasma was tested by PCR for HHV-6, HHV-8, cytomegalovirus, and Epstein-Barr virus DNA, and saliva was examined for HHV-8 DNA. For all assays, results did not differ between the group of twins with CFS and the healthy twins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173124     DOI: 10.1086/341774

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

Review 1.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

3.  Cold pressor pain sensitivity in monozygotic twins discordant for chronic fatigue syndrome.

Authors:  Philip M Ullrich; Niloofar Afari; Clemma Jacobsen; Jack Goldberg; Dedra Buchwald
Journal:  Pain Med       Date:  2007-04       Impact factor: 3.750

4.  Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study.

Authors:  S-Y Tsai; T-Y Yang; H-J Chen; C-S Chen; W-M Lin; W-C Shen; C-N Kuo; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

5.  Xenotropic murine leukemia virus-related virus in monozygotic twins discordant for chronic fatigue syndrome.

Authors:  Keith R Jerome; Kurt Diem; Meei-Li Huang; Stacy Selke; Lawrence Corey; Dedra Buchwald
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07-26       Impact factor: 2.803

Review 6.  Review part 2: Human herpesvirus-6 in central nervous system diseases.

Authors:  Karen Yao; John R Crawford; Anthony L Komaroff; Dharam V Ablashi; Steven Jacobson
Journal:  J Med Virol       Date:  2010-10       Impact factor: 2.327

7.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder.

Authors:  Elling Ulvestad
Journal:  Med Health Care Philos       Date:  2008-02-21

Review 9.  Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis.

Authors:  Stefania Fulle; Tiziana Pietrangelo; Rosa Mancinelli; Raoul Saggini; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2008-02-15       Impact factor: 2.698

10.  Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Authors:  Marta Curriu; Jorge Carrillo; Marta Massanella; Josepa Rigau; José Alegre; Jordi Puig; Ana M Garcia-Quintana; Jesus Castro-Marrero; Eugènia Negredo; Bonaventura Clotet; Cecilia Cabrera; Julià Blanco
Journal:  J Transl Med       Date:  2013-03-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.